Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis
NEWARK, CA, March 8, 2025 (Ecnetnews.com) - Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced new icotrokinra (JNJ-2113) data ...